| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/13/2004 | US6677316 Adenosine derivatives and methods of administration |
| 01/13/2004 | US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677298 Protein antagonist; antidiabetic agents, antilipemic agents |
| 01/13/2004 | US6677145 Isolating a nucleotide sequence having specific sequence, constructing a vector consists of an isolated nucleotide sequence operably linked to a promoter, introducing the vector into host cell for expression of elongase enzyme |
| 01/13/2004 | US6677136 Glucagon antagonist domain, preferably having very little or no glucagon agonist activity, yeast-based screening phage display, rna- peptide screening, etc. attached to a vehicle, e.g., an fc domain, peg or dextran |
| 01/13/2004 | US6676979 Laxative; anticholesterol agents |
| 01/13/2004 | US6676939 Methods of modulating IL-174 response |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003201A2 Antisense modulation of lrh1 expression |
| 01/08/2004 | WO2004003179A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004002987A1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | WO2004002535A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002530A1 Remedy for chronic disease |
| 01/08/2004 | WO2004002513A2 Proteins involved in the regulation of energy homeostasis |
| 01/08/2004 | WO2004002512A1 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 01/08/2004 | WO2004002492A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2004002481A1 Aryl carbonyl derivatives as therapeutic agents |
| 01/08/2004 | WO2004002480A1 Novel glucagon antagonists/inverse agonists |
| 01/08/2004 | WO2004002474A1 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/08/2004 | WO2004002473A1 Drug composition for blood sugar control |
| 01/08/2004 | WO2004002461A2 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002241A1 Satiety inducing composition |
| 01/08/2004 | WO2004002239A2 Purified amylase inhibitor and novel process for obtaining the same |
| 01/08/2004 | WO2004002238A1 Nutritional composition for detoxification and cancer prevention |
| 01/08/2004 | WO2003092647A3 Transport system in biological systems |
| 01/08/2004 | WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/08/2004 | WO2003087174A3 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/08/2004 | WO2003087139A3 Treatment of gastroparesis |
| 01/08/2004 | WO2003087088A3 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/08/2004 | WO2003086315A3 Tyrosine kinase inhibitors |
| 01/08/2004 | WO2003075850A3 Methods for alzheimer's disease treatment and cognitive enhancement |
| 01/08/2004 | WO2003070969A3 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/08/2004 | WO2003070166A3 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2003061604A3 Novel alkyl/aryl hydroxy or keto thiepines. |
| 01/08/2004 | WO2003047618A3 Immunotherapeutic methods and systems |
| 01/08/2004 | WO2003020257A3 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 01/08/2004 | WO2003007923A3 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002080952A3 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002072780A3 Igf antagonist peptides |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 01/08/2004 | WO2002053522A3 Novel estrogen receptor ligands and methods i |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | US20040006242 Immunomodulatory compounds and method of use thereof |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006141 Amidocarboxylic acid compounds |
| 01/08/2004 | US20040006139 As a food additive, as an animal food additive, as dietary substances, for improving general performances in the fields of sport, strength and endurance areas and, in deficiencies and illnesses of the central and/or peripheral nervous system |
| 01/08/2004 | US20040006129 Administering compound selected from 4,4'-(isopropylidenedithio) bis(2,6-di-tert-butylphenol), 2,3-Dihydro-5-hydroxy-2 2-dipentyl-4,6-di-tert-butyl-benzofuran, vitamin E and vitamin c |
| 01/08/2004 | US20040006128 Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels |
| 01/08/2004 | US20040006120 Administering to a patient in need of such weight loss or treatment an effective amount of an inverse agonist of histamine H3 receptors, with the proviso that inverse agonist is not thioperamide |
| 01/08/2004 | US20040006116 For therapy of non-insulin dependent diabetes mellitus |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006097 For therapy of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis |
| 01/08/2004 | US20040006095 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 01/08/2004 | US20040006092 Amidine derivatives for treating amyloidosis |
| 01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
| 01/08/2004 | US20040006082 For therapy and prophylaxis of diabetes, diabetic complications, diabetic retinopathy, obesity or asthma, hypoglycemic agent, an improving agent for impaired glucose tolerance, a potentiating agent for insulin sensitivity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006079 Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | US20040006046 For therapy and prophylaxis of hyperglycemia |
| 01/08/2004 | US20040006025 As diabetic-medicine which is easy to synthesize, less toxic and has higher curative effect |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040006004 This invention concerns a method for treating or preventing a disease or disorder related to excessive formation of vascular tissue or blood vessels in a patient, said method comprising administering to said patient an agent affecting the NPY Y2 |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005588 Using DNA vaccines to treat and prevent insulin depentent diabetes mellitus |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005305 Nutritional composition for treating an immune condition |
| 01/08/2004 | US20040005299 Method for producing pseudo islets |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | DE10227793A1 Stabilisierte Cholinascorbat enthaltende Zusammensetzung Stabilized choline-containing composition |
| 01/08/2004 | DE10227508A1 Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Acid group-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | DE10227507A1 Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Cationically substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |